Nephrology and urology
A non-invasive low-intensity shockwave system investigated in atherosclerotic renal artery stenosis, hypertension and chronic kidney disease.
Homepage › Nephrospec™
In short: Nephrospec is a low-intensity shockwave system developed for renal artery narrowing (ARAS), hypertension and chronic kidney disease. It aims to improve microcirculation by supporting the formation of new blood vessels in the kidney.
Atherosclerotic renal artery stenosis (ARAS) is a narrowing of the artery supplying the kidney. It can lead to hypertension, loss of kidney function and cardiovascular problems. Although procedures such as stenting open the narrowed vessel, they cannot repair damage to the small vessels inside the kidney (microvascular rarefaction).
Nephrospec delivers deep-focused low-intensity shockwaves to the kidney. By increasing factors that trigger blood vessel formation, these waves are intended to support the restructuring of microcirculation inside the kidney.
For physician information and clinical data on Nephrospec, contact us.
Last updated: November 2026. This page was prepared by the Bold Sağlık editorial team for general information purposes and does not replace a medical examination.
Contact us to find the ED1000 centre nearest you and arrange a preliminary consultation.
On this page
Related pages
Nephrospec is a low-intensity extracorporeal shockwave (Li-ESWT) system investigated in atherosclerotic renal artery stenosis, hypertension and chronic kidney disease.
Experimental and clinical studies have shown that Li-ESWT can improve microcirculation and oxygenation by supporting the formation of new blood vessels in the kidney.
Suitability is assessed by nephrology and urology specialists. Nephrospec is considered an additional option alongside standard treatments.